HomeNewsHealth & FitnessCOVID-19 update | Centre issues fresh SOPs, allows offices to resume work after disinfection

COVID-19 update | Centre issues fresh SOPs, allows offices to resume work after disinfection

Work can resume after disinfection has been completed as per laid down protocols, the standard operating procedures (SOPs), which were issued on Saturday.

February 14, 2021 / 21:22 IST
Story continues below Advertisement
The vaccination drive in India commenced on January 16. (AP)
The vaccination drive in India commenced on January 16. (AP)

The Union health ministry has issued new 'SOPs to contain spread of COVID-19 in offices' and according to these, if one or two cases are reported, the disinfection procedure will be limited to the areas occupied and visited by the patient in the last 48 hours. Work can resume after disinfection has been completed as per laid down protocols, the standard operating procedures (SOPs), which were issued on Saturday, stated.

If a larger number of cases are reported at workplace, the whole block or building should be disinfected before work is resumed, the ministry said. Officers and staff residing in containment zones should inform the same to their supervisory officer and not attend office till the containment zone is denotified. Such staff should be permitted to work from home, the new SOPs stated.

Story continues below Advertisement

India's COVID-19 recovery rate at 97.31%, among highest in world: Health Ministry

Offices in containment zones shall remain closed except for medical and essential services and only those outside will be allowed to open up, the document said. The SOPs stated that only asymptomatic staff or visitors shall be allowed entry, individuals must maintain a minimum distance of six feet in common places as far as feasible, and use face covers or masks at all times.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show